Efficacy and glucocorticoid sparing of dupilumab in IgG4-related disease: a case series and literature review
These preliminary findings need to be confirmed, but may offer arguments in favour of a possible efficacy of dupilumab in the treatment of IgG4-RD.
Authors
- Achille Aouba (ORCID: https://orcid.org/0000-0003-1726-3811)
- Ondine Walter (ORCID: https://orcid.org/0000-0003-0869-7917)
- Chantal Rahérison (ORCID: https://orcid.org/0000-0003-0015-2883)
- N. Schleinitz (ORCID: https://orcid.org/0000-0001-9449-3392)
- Flora Finet
- Alban Deroux (ORCID: https://orcid.org/0000-0002-9098-7368)
- Lucile Sesé (ORCID: https://orcid.org/0000-0002-6886-1793)
- M. Trénec
- S. Abad (ORCID: https://orcid.org/0000-0001-6401-7088)
- Benjamin Terrier (ORCID: https://orcid.org/0000-0001-6612-7336)
- Robin Dhôte (ORCID: https://orcid.org/0000-0001-9969-9947)
Institutions
- Centre Hospitalier Universitaire de Toulouse (FR)
- Assistance Publique – Hôpitaux de Paris (FR)
- Centre Hospitalier Universitaire de Caen Normandie (FR)
- Hôpital Avicenne (FR)
- Université de Caen Normandie (FR)
Publication Details
- Journal
- Clinical and Experimental Rheumatology
- Published
- 2024-11-29
- DOI
- https://doi.org/10.55563/clinexprheumatol/nui493
- Primary Topic
- IgG4-Related and Inflammatory Diseases
- Type
- article
- Field-Weighted Citation Impact
- 0.00